Product Description
CG428 is a botanical lotion intended to help hair recovery after chemotherapy hair loss.
Mechanisms of Action: TRK Degrader
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Topical
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Samsung
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Alopecia Areata
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT02605629 |
VOLUME | N/A |
Completed |
Alopecia |
2017-06-09 |
2019-03-20 |
Treatments |
|
NCT02986412 |
VOLUME2 | N/A |
Completed |
Alopecia |
2016-12-15 |
2019-03-21 |
Treatments |
|
NCT02919735 |
ELAN | P2 |
Completed |
Alopecia Areata |
2018-07-01 |
2019-08-14 |
Primary Endpoints|Study Completion Date|Treatments |